<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119870">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01542385</url>
  </required_header>
  <id_info>
    <org_study_id>PRIMACY</org_study_id>
    <nct_id>NCT01542385</nct_id>
  </id_info>
  <brief_title>Primary Reperfusion Secondary Stenting Trial</brief_title>
  <acronym>PRIMACY</acronym>
  <official_title>Immediate vs. Delayed Stenting After Primary Percutaneous Reperfusion in ST Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montreal Heart Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PRIMACY trial seeks to assess whether a strategy of delayed stent implantation combined
      with adjunctive anticoagulation is superior to immediate stent implantation at improving
      cardiovascular outcomes in patients with mechanically reperfused ST-elevation Myocardial
      Infarction (STEMI). The investigators hypothesize that delayed stent implantation combined
      with systemic anticoagulation and maximal antiplatelet therapy will reduce the combined
      occurrence of cardiac death, non-fatal myocardial infarction, congestive heart failure, and
      target vessel revascularization at 90 days.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The combined occurence of cardiac death, non-fatal myocardial infarction, congestive heart failure, and urgent target vessel revascularization</measure>
    <time_frame>90 days</time_frame>
    <description>As defined by standardized definitions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>90 days</time_frame>
    <description>As defined by the Bleeding Academic Research Consortium (BARC).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">208</enrollment>
  <condition>ST-elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Immediate stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed stenting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous coronary intervention</intervention_name>
    <description>Percutaneous coronary intervention: reperfusion with a thrombectomy catheter or a small balloon angioplasty catheter, followed by coronary stenting</description>
    <arm_group_label>Immediate stenting</arm_group_label>
    <arm_group_label>Delayed stenting</arm_group_label>
    <other_name>Thrombectomy catheter</other_name>
    <other_name>Balloon angioplasty catheter</other_name>
    <other_name>Coronary stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 18 and 80 years;

          2. STEMI, presenting within 12 hours of symptoms onset, and persisting for more than 20
             minutes;

          3. ECG that fulfills any of the following criteria: ≥ 2 mm ST elevation in two anterior
             or lateral leads; or ≥ 1 mm ST elevation in two inferior leads; or new left bundle
             branch block (LBBB) with at least 1 mm concordant ST elevation;

          4. Infarct-related artery with TIMI flow 0 or 1 at baseline angiogram;

          5. Successful reperfusion (TIMI 2-3 flow), either spontaneously or after wire passage,
             thrombectomy, small size (≤ 2.0mm) angioplasty catheter, and persisting for more than
             10 minutes;

          6. Infarct related artery with a diameter above 2.5 mm.

        Exclusion Criteria:

          1. Prior STEMI in the qualifying coronary artery;

          2. Coronary dissection following reperfusion;

          3. STEMI caused by acute stent thrombosis or a venous or arterial bypass graft
             occlusion;

          4. Significant left main disease, as determined by angiography (≥ 50%) or other imaging
             technologies;

          5. Cardiac condition requiring emergent or urgent surgical repair;

          6. Failed thrombolysis and rescue PCI;

          7. High risk of bleeding;

          8. Contraindication to either ticagrelor or GpIIb/IIIa inhibitors;

          9. STEMI with Killip III-IV or cardiogenic shock or presenting as sudden death,
             ventricular fibrillation, or sustained ventricular tachycardia;

         10. Women who are pregnant or breastfeeding;

         11. Creatinine clearance &lt; 20 ml/min;

         12. Other contraindication to PCI;

         13. Participation with another investigational drug or investigational device study
             within 30 days prior to randomization (participation to registries is allowed);

         14. Any condition that in the opinion of the investigator would preclude compliance with
             the study protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc E Jolicoeur, MD MSc MHS</last_name>
    <role>Study Chair</role>
    <affiliation>Montreal Heart Institute, Université de Montréal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lawrence Joseph, PhD</last_name>
    <role>Study Director</role>
    <affiliation>McGill University Health Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Caude Tardif, MD</last_name>
    <role>Study Director</role>
    <affiliation>Montreal Heart Institute, Université de Montréal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc E Jolicoeur, MD MSc MHS</last_name>
    <phone>514-376-3330</phone>
    <email>marc.jolicoeur@icm-mhi.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luc Harvey, RN BSc</last_name>
    <phone>514-376-3330</phone>
    <phone_ext>2776</phone_ext>
    <email>luc.harvey@icm-mhi.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Thunder Bay Regional Health Sciences Center</name>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <zip>P7B 6V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melanie Scavarelli</last_name>
      <phone>807-684-6044</phone>
      <email>scavarme@tbh.net</email>
    </contact>
    <investigator>
      <last_name>Ian Billingsley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CSSS de Chicoutimi</name>
      <address>
        <city>Chicoutimi</city>
        <state>Quebec</state>
        <zip>G7H 5H6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc Harvey</last_name>
      <phone>5143763330</phone>
      <phone_ext>2776</phone_ext>
      <email>luc.harvey@icm-mhi.org</email>
    </contact>
    <contact_backup>
      <last_name>Marie-Gabrielle Lessard</last_name>
      <phone>5143763330</phone>
      <phone_ext>2094</phone_ext>
      <email>marie-gabrielle.lessard@icm-mhi.org</email>
    </contact_backup>
    <investigator>
      <last_name>Marc Jolicoeur</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHUM-Hôtel-Dieu de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renée Duclos</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>14803</phone_ext>
      <email>renee.duclos.chum@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Samer Mansour</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital du Sacré Cœur de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantale Mercure</last_name>
      <phone>514-338-2222</phone>
      <phone_ext>3721</phone_ext>
      <email>c-mercure@crhsc.rtss.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Erick Schampaert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional de Lanaudière</name>
      <address>
        <city>St-Charles-Borromée</city>
        <state>Quebec</state>
        <zip>J6E 6J2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHR CSSS de Trois Rivières</name>
      <address>
        <city>Trois Rivières</city>
        <state>Quebec</state>
        <zip>G8Z 3R9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH de Cannes</name>
      <address>
        <city>Cannes</city>
        <zip>06401</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles Zemour</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>géraud Souteyrand</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Louis-Pasteur</name>
      <address>
        <city>Le Coudray</city>
        <zip>28360</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gérgoire Range</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Annecy Genevois</name>
      <address>
        <city>Metz-Tessy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Belle</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ch de Montpellier-Hôpital A. de Villneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois Roubille</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Pau</name>
      <address>
        <city>Pau</city>
        <zip>64000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Delarche</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse-Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bouisset Fréderic</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Vichy</name>
      <address>
        <city>Vichy</city>
        <zip>03200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Marcaggi</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.onlinecjc.ca/article/S0828-282X(11)00400-4/fulltext</url>
    <description>Canadian Journal of Cardiology Editorial</description>
  </link>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 26, 2016</lastchanged_date>
  <firstreceived_date>February 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montreal Heart Institute</investigator_affiliation>
    <investigator_full_name>Marc Jolicoeur</investigator_full_name>
    <investigator_title>E. Marc Jolicoeur, MD MSc MHS FRCP-C FACC</investigator_title>
  </responsible_party>
  <keyword>Delayed stenting</keyword>
  <keyword>Deferred stenting</keyword>
  <keyword>Late stenting</keyword>
  <keyword>postponed stenting</keyword>
  <keyword>Thrombectomy</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>PCI</keyword>
  <keyword>Angioplasty</keyword>
  <keyword>STEMI</keyword>
  <keyword>acute myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
